| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |